FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology. For the combined treatment of glaucoma in combination with cataract, the first stage is transscleral cyclophotocoagulation in micropulse mode using a diode laser with a wavelength of 810 nm and an exposure of 80 s, along a circular arc 160° long in the lower and upper hemispheres of the eyeball, 3-4 mm from the limbus , with an energy of 1800-2500 mJ, with a duty cycle of 31.3%, a pulse duration of 0.5 ms, a period of 1.1 ms. Then, the second stage is cataract phacoemulsification with intraocular lens implantation.
EFFECT: method allows to reduce the duration of treatment, improve visual functions, reduce intraocular pressure, stabilize the glaucoma process, reduce the risk of side intra- and postoperative complications.
3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMBINED TREATMENT OF SEVERE FORMS OF REFRACTORY GLAUCOMA | 2020 |
|
RU2741373C1 |
METHOD OF COMBINED TREATMENT OF PRIMARY CLOSED-ANGLE GLAUCOMA | 2020 |
|
RU2741374C1 |
METHOD OF COMBINED SURGICAL TREATMENT OF SECONDARY GLAUCOMA CAUSED BY EMULSIFICATION OF SILICONE | 2018 |
|
RU2688960C1 |
METHOD OF COMBINED LASER TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2798323C1 |
METHOD OF TWO-STAGE SURGICAL TREATMENT OF CATARACT IN COMBINATION WITH PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2796869C1 |
METHOD OF COMBINED LASER TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA WITH ANY DEGREE OF TRABECULAR PIGMENTATION | 2023 |
|
RU2805396C1 |
METHOD OF COMBINED SURGICAL TREATMENT OF SECONDARY GLAUCOMA IN POSTTRAUMATIC ANIRIDIA | 2015 |
|
RU2588396C1 |
METHOD OF COMBINED TREATMENT OF SEVERE FORMS OF SECONDARY NEOVASCULAR GLAUCOMA | 2019 |
|
RU2708059C1 |
METHOD OF COMBINED SURGICAL TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2018 |
|
RU2688974C1 |
METHOD OF COMBINED TREATMENT OF SECONDARY NEOVASCULAR GLAUCOMA AT EARLY STAGES | 2019 |
|
RU2708045C1 |
Authors
Dates
2022-04-06—Published
2021-11-18—Filed